tradingkey.logo
tradingkey.logo
Search

Bionano Genomics Inc

BNGO
Add to Watchlist
1.150USD
-0.020-1.71%
Close 07/02, 13:00ETQuotes delayed by 15 min
12.35MMarket Cap
LossP/E TTM

More Details of Bionano Genomics Inc Company

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc Info

Ticker SymbolBNGO
Company nameBionano Genomics Inc
IPO dateAug 01, 2018
CEOHolmlin (R. Erik)
Number of employees98
Security typeOrdinary Share
Fiscal year-endAug 01
Address9540 Towne Centre Drive
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18588887600
Websitehttps://bionano.com/
Ticker SymbolBNGO
IPO dateAug 01, 2018
CEOHolmlin (R. Erik)

Company Executives of Bionano Genomics Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

FAQs

Who are the top five shareholders of Bionano Genomics Inc?

The top five shareholders of Bionano Genomics Inc are: Mr. Mark Oldakowski

How many institutions hold shares of Bionano Genomics Inc (BNGO)?

As of 2026Q1, 109 institutions hold shares of Bionano Genomics Inc, with a combined market value of approximately 1.17M, accounting for 10.52% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 32263.00.

What is the biggest source of revenue for Bionano Genomics Inc?

In 2026Q1, the Consumables business generated the highest revenue for Bionano Genomics Inc, amounting to 13.97M and accounting for 49.00% of total revenue.